latanoprost + dorzolamide

Latanoprost + dorzolamide is a fixed-dose combination ophthalmic medication used to reduce elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Latanoprost is a prostaglandin F2 alpha analog that increases the outflow of aqueous humor, thereby lowering intraocular pressure. Dorzolamide is a carbonic anhydrase inhibitor that decreases aqueous humor production by inhibiting the enzyme carbonic anhydrase in the ciliary processes of the eye. The combination leverages complementary mechanisms to achieve greater intraocular pressure reduction than either agent alone, and it is typically administered as topical eye drops.

Other names

ALZ-1101ALZ1101ALZ 1101